Catalysts of change: Immunotherapy's frontier in oral oncology
Oral cancer, which is a kind of HNSCC, presents considerable experimental difficulties because of its high rates of illness and death, often being identified at late stages. Although there have been improvements in conventional treatments such surgery, radiation, and chemotherapy, the outlook for pa...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Elsevier
2024-09-01
|
| Colección: | Oral Oncology Reports |
| Materias: | |
| Acceso en línea: | http://www.sciencedirect.com/science/article/pii/S2772906024004473 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
